The Efficacy and Safety of Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Nasopharyngeal Carcinoma: Literature-based Meta-analyses

Background: Anti-epidermal growth factor receptor monoclonal antibodies (anti-EGFR mAbs), such as cetuximab and nimotuzumab have been used in the treatment of nasopharyngeal carcinoma (NPC), yet their efficacy and safety are undetermined. Materials and Methods: We performed two meta-analyses based o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer
Hlavní autoři: Peng, Liang, Liu, Ze-Long, Xu, Cheng, Tang, Ling-Long, Liu, Xu, Lin, Ai-Hua, Sun, Ying, Chen, Yu-Pei, Ma, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2018
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277641/
https://ncbi.nlm.nih.gov/pubmed/30519357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27611
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky